Open AccessPrognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
Author(s) -
Peng Yan,
Yiming Han,
Anna Tong,
Jie Liu,
Xinyu Wang,
Chuanyong Liu
Publication year - 2021
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20210866
Subject(s) - enolase , medicine , univariate analysis , lung cancer , multivariate analysis , hazard ratio , gastroenterology , oncology , progression free survival , overall survival , immunohistochemistry , confidence interval
Increased serum neuron-specific enolase (NSE) level was found in a substantial proportion (30-69%) of patients with non-small-cell lung cancer (NSCLC), but little was known about the clinical properties of NSE in NSCLC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom